share_log

BioVie | 4: Statement of changes in beneficial ownership of securities-Officer DO CUONG V

SEC ·  Jul 13, 2024 06:02

Summary by Futu AI

BioVie Inc. President & CEO, Do Cuong V, completed a series of stock transactions between February 15, 2024, and June 24, 2024. On February 16, 2023, Do Cuong V disposed of 4,953 shares of common stock at a price of $5.51 per share, followed by another disposal of 4,953 shares at $1.18 each on February 15, 2024. The most recent transaction on June 24, 2024, involved the disposal of 42,000 shares at $0.474 each. Additionally, on June 24, 2024, Do Cuong V acquired 168,000 shares at no cost, which was described as a grant, award, or other acquisition. After these transactions, Do Cuong V holds a total of 551,948 shares in indirect ownership. The total market value of the disposed shares amounted to $53,043.57.
BioVie Inc. President & CEO, Do Cuong V, completed a series of stock transactions between February 15, 2024, and June 24, 2024. On February 16, 2023, Do Cuong V disposed of 4,953 shares of common stock at a price of $5.51 per share, followed by another disposal of 4,953 shares at $1.18 each on February 15, 2024. The most recent transaction on June 24, 2024, involved the disposal of 42,000 shares at $0.474 each. Additionally, on June 24, 2024, Do Cuong V acquired 168,000 shares at no cost, which was described as a grant, award, or other acquisition. After these transactions, Do Cuong V holds a total of 551,948 shares in indirect ownership. The total market value of the disposed shares amounted to $53,043.57.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    ImmunoPrecise Antibodies
    IPA
    -- 0.760
    Nutriband
    NTRB
    -- 6.790
    Absci Corp
    ABSI
    -- 4.090
    Metagenomi Technologies, LLC
    MGX
    -- 3.350
    Seres Therapeutics
    MCRB
    -- 0.895
    Log In for the Full List
    Latest
    00:06
    Deutsche Bank: The action of UniCredit in increasing its shareholding in our company is seen as "hostile."
    00:06
    Arabica coffee Futures rose by more than 3%, reaching $3.3835 per pound.
    00:02
    The chairman of the Board of Directors and CEO of Merck Group, Bellinda, stated that the problems currently faced by Europe are not related to the recent USA elections, and issues such as how to enhance Europe's competitiveness have long existed. Some issues stem from excessive regulation, but this is not the only reason. Europe's technological lag in areas such as AI is primarily due to market fragmentation and insufficient investment. However, changes in USA policy may indeed further encourage Europe to accelerate its pace of action. Europe should enhance the efficiency of regulatory policies, develop clearer and more predictable policies, shorten regulatory timelines in data protection and other areas, and support Technology innovation rather than impose excessive restrictions.
    MRK-0.57%
    Investment Course
    Choose stocks based on financial reports
    Quickly master financial season learning guidelines
    When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
    In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
    When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
    【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
    As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney